IP Library Granted Patent US 10,774,157
Granted Patent B2
US 10,774,157 · App. 15/779,424 · Granted Sep 15, 2020

Multispecific antibodies

Inventor: Michael John Wright (Slough, GB)
Assignee: UCB BIOPHARMA SRL
C07K16/468C07K14/39C07K16/00C07K16/14C07K2317/31C07K2317/34C07K2317/55C07K2317/622C07K2319/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,774,157
App. No.
15/779,424
Granted
Sep 15, 2020
Kind
B2
Abstract

The present invention relates to heterodimerically-tethered bispecific protein complexes (according to the general formula of A(A 1 )n-X:Y-B(B 1 )m and libraries/multiplexes thereof for use in research and therapy and in particular an in vitro/ex vivo method of detecting synergistic biological function of otherwise unknown pairs of targets. Such complexes may be used to capture soluble molecules secreted from a particular cell, in therapy, in research and for experimental purposes such as in assays to characterise patient populations by identifying cell populations relevant to a pathology or prognosis.

Claims (38)

1. A multispecific protein complex having the formula A(A 1 )n-X:Y-B(B 1 )m wherein:

A(A 1 )n-X is a first fusion protein;

Y-B(B 1 )m is a second fusion protein;

X:Y is a heterodimeric-tether;

: is a binding interaction between X and Y;

wherein A is a Fab or sdAb;

B is a Fab;

A 1 and B 1 are independently a scFv or a sdAb,

n is 0 or 1,

m is 0 or 1,

with the proviso that at least one of n or m is 1;

wherein X is an antigen or an antibody or binding fragment thereof, and said X is appended to the N-terminal or to the C-terminal of A or of A 1 ; and

Y is an antigen or an antibody or a binding fragment thereof, and said Y is appended to the N-terminal or to the C-terminal of B or of B 1 ;

wherein when X is appended to A, A 1 is appended to the N-terminal or to the C-terminal of A which is not occupied by X;

wherein when Y is appended to B, B 1 is appended to the N-terminal or to the C-terminal of B which is not occupied by Y;

wherein X is a first binding partner of a binding pair selected from an antigen, an antibody, and a binding fragment of the antibody, wherein when X is an antigen, Y is an antibody or binding fragment thereof specific to the antigen represented by X; or wherein when Y is an antigen, X is an antibody or binding fragment thereof specific to the antigen represented by Y; and wherein X or Y is a scFv specific to the peptide GCN4 having SEQ ID NO: 1 or amino acids 1 to 38 of SEQ ID NO: 1 and wherein the scFv is 525R4 comprising SEQ ID NO:3 or amino adds 1 to 243 of SEQ ID NO:3; or wherein X or Y is a peptide GCN4 comprising SEQ ID NO:1 or amino acids 1 to 38 of SEQ ID NO: 1.

2. The multispecific protein complex according to claim 1 :

wherein A is a Fab comprising a heavy and light chain;

wherein B comprises a heavy and light chain;

wherein X is appended to the C-terminal of a light chain or heavy chain of the Fab of A; and

wherein Y is a second binding partner of the binding pair independently selected from an antigen, an antibody, and a binding fragment of the antibody, and said Y is appended to the C-terminal of a light chain or heavy chain of the Fab of B;

A 1 is a scFv or a sdAb appended from the C-terminal of the heavy or light chain of the Fab of A which is not occupied by X,

B 1 is a scFv or a sdAb appended from the C-terminal of the heavy or light chain of the Fab of B which is not occupied by Y.

3. The multispecific protein complex according to claim 1 , wherein A is a Fab.

4. The multispecific protein complex according to claim 1 , wherein A is a Fab and X is fused to the C-terminal of the heavy chain in the Fab of A.

5. The multispecific protein complex according to claim 1 , wherein Y is fused to the C-terminal of the heavy chain in the Fab of B.

6. The multispecific protein complex according to claim 1 , wherein X is a scFv specific to the peptide GCN4 having SEQ ID NO: 1 or amino acids 1 to 38 of SEQ ID NO: 1.

7. The multispecific protein complex according to claim 1 , wherein Y is a scFv the peptide GCN4 having SEQ ID NO: 1 or amino acids 1 to 38 of SEQ ID NO: 1.

8. The multispecific protein complex according to claim 1 , wherein the binding affinity between X and Y is from 5 nM to 300 pM.

9. The multispecific protein complex according to claim 8 , wherein the binding affinity between X and Y is 900 pM, 800 pM, 700 pM, 600 pM, 500 pM, 400 pM or 300 pM.

10. The multispecific protein complex according to claim 1 , wherein X or Y is a scFv specific to the peptide GCN4 (SEQ ID NO:1 or amino acids 1 to 38 of SEQ ID NO:1).

11. The multispecific protein complex according to claim 10 , wherein the scFv is 52SR4 (SEQ ID NO:3 or amino acids 1 to 243 of SEQ ID NO:3).

12. The multispecific protein complex according to claim 1 , wherein X or Y is a peptide GCN4 (SEQ ID NO:1 or amino acids 1 to 38 of SEQ ID NO:1).

13. The multispecific protein complex according to claim 1 , wherein A and/or B is specific for: a cell surface receptor.

14. The multispecific protein complex according to claim 1 , wherein A 1 and/or B 1 is specific for: a cell surface receptor.

15. The multispecific protein complex according to claim 1 , wherein at least one of A, A 1 , B or B 1 is specific to a cell marker.

16. The multispecific protein complex according to claim 15 , wherein the cell marker is selected from a B cell marker and T cell marker.

17. A composition comprising one or more multispecific protein complexes defined in claim 1 .

Assignments (2)
CHANGE OF NAME Recorded Sep 23, 2021
From: UCB BIOPHARMA SPRL
To: UCB BIOPHARMA SRL
Reel/Frame 057595/0596 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2018
From: WRIGHT, MICHAEL JOHN
To: UCB BIOPHARMA SPRL
Reel/Frame 046010/0431 →
Priority Claims (1)
GB 1521393.7 · Dec 3, 2015 · national
Continuity (1)
Related Publication 20180334514A1 · Nov 22, 2018
Cited By (1)
US 12,331,117